Dicyclomine

• Irritable bowel syndrome (IBS) symptom relief
• Functional gastrointestinal disorders
• Abdominal cramping and spasms
• Gastrointestinal smooth muscle relaxation

Dicyclomine is an anticholinergic and antispasmodic medication used primarily to treat the symptoms of irritable bowel syndrome (IBS) and other functional gastrointestinal disorders. By relaxing smooth muscle in the gastrointestinal tract, it reduces painful cramping, bloating, and altered bowel habits that characterize these conditions.

Mechanism of Action

Dicyclomine exerts its therapeutic effects through two complementary mechanisms. First, it acts as a muscarinic receptor antagonist, blocking the action of acetylcholine on smooth muscle cells in the gastrointestinal tract. This reduces the involuntary muscle contractions that cause cramping and pain. Second, dicyclomine has a direct relaxant effect on smooth muscle, independent of its anticholinergic activity. This dual mechanism makes it effective for relieving the abdominal spasms and discomfort associated with IBS and other functional bowel disorders.

The anticholinergic properties of dicyclomine also affect other organ systems, which accounts for both additional therapeutic effects (such as reduced gastric acid secretion) and side effects (such as dry mouth and urinary retention).

Available Formulations

Dicyclomine (Bentyl) is available in several formulations to accommodate different patient needs. Oral capsules come in 10 mg strength, while oral tablets are available in 20 mg strength. An oral solution (10 mg/5 mL) provides flexibility for patients who have difficulty swallowing tablets or require dose adjustments. An injectable formulation (10 mg/mL) is available for intramuscular use in acute situations when oral administration is not possible.

FDA-Approved Indications

Dicyclomine is FDA-approved for the treatment of functional bowel/irritable bowel syndrome. While this is the primary labeled indication, the medication is also used off-label for various other conditions involving gastrointestinal smooth muscle spasm, including diverticulitis-associated pain, infantile colic, and as an adjunctive treatment in peptic ulcer disease.

Dosing Guidelines

For adults with IBS, the typical starting dose is 20 mg orally four times daily. After at least one week, if tolerated and if efficacy is not adequate, the dose may be increased to 40 mg four times daily. The medication should be taken before meals and at bedtime for optimal effect. If significant side effects occur, the dose should be reduced until a tolerable level is reached. The intramuscular formulation should not be used for more than 1-2 days, as oral administration should be initiated as soon as possible.

Therapeutic Considerations

Dicyclomine is most effective when used as part of a comprehensive IBS management strategy that includes dietary modifications, stress management, and lifestyle changes. The medication works best for IBS patients whose symptoms are dominated by cramping, pain, and urgency rather than constipation, as anticholinergic effects can worsen constipation. Patients should be counseled that the medication treats symptoms rather than the underlying condition and that some trial and adjustment may be needed to find the optimal dose.

Important Safety Considerations

Dicyclomine is contraindicated in infants younger than 6 months due to reports of serious respiratory symptoms, seizures, and death in this population. It should also be avoided in patients with obstructive uropathy, obstructive GI disease, severe ulcerative colitis, myasthenia gravis, and unstable cardiovascular status. Heat prostration can occur with use in hot environments due to decreased sweating. Elderly patients are particularly susceptible to anticholinergic effects and should be monitored closely.

Drug Interactions

Dicyclomine may interact with other anticholinergic medications, leading to additive effects and increased risk of adverse reactions. It can reduce gastric motility, potentially affecting the absorption of other oral medications. The medication should be used cautiously with drugs that slow GI motility (opioids) and with medications that have anticholinergic properties (antihistamines, tricyclic antidepressants, phenothiazines). Antacids may decrease dicyclomine absorption; separate administration by at least 2 hours.

Special Populations

Use in patients over 65 years requires caution due to increased sensitivity to anticholinergic effects, including confusion, constipation, and urinary retention. The medication should be used during pregnancy only if clearly needed, as safety has not been established. Dicyclomine passes into breast milk and may reduce milk production; use during breastfeeding requires careful consideration of benefits and risks.

Learn more at MedlinePlus